Independent prognostic value of the basal‐like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI‐1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Histopathology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.2007.02957.xPMID 18269588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa

  2006cited by this paper
• Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

  2006cited by this paper
• Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

  2006cited by this paper
• EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

  2006cited by this paper
• Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.

  2006cited by this paper
• ErbB‐receptors expression and survival in breast carcinoma: A 15‐year follow‐up study

  2006cited by this paper
• Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas

  2006cited by this paper
• EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.

  2006cited by this paper
• Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.

  2005cited by this paper
• EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

  2005cited by this paper
• Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.

  2005cited by this paper
• Diagnostic value of OCT3/4 for pre‐invasive and invasive testicular germ cell tumours

  2005cited by this paper
• Oct4 pseudogenes are transcribed in cancers.

  2005cited by this paper
• Stem cell-ness: a "magic marker" for cancer.

  2005cited by this paper
• Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors

  2005cited by this paper
• Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry.

  2005cited by this paper
• Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

  2005cited by this paper
• Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa).

  2005cited by this paper
• Expression and prognostic value of EGFR in invasive breast cancer.

  2005cited by this paper
• Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer

  2005cited by this paper
• OCT4: A Novel Biomarker for Dysgerminoma of the Ovary

  2004cited by this paper
• Self-renewal and solid tumor stem cells

  2004cited by this paper
• Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

  2004cited by this paper
• β‐Catenin and p53 analyses of a breast carcinoma tissue microarray

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry

  2004cited by this paper
• Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

  2004cited by this paper
• BRCA1 functions as a breast stem cell regulator

  2004cited by this paper
• Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Oct-3/4 is a dose-dependent oncogenic fate determinant.

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

  2003cited by this paper
• Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

  2003cited by this paper
• Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

  2003cited by this paper
• Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

  2003cited by this paper
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

  2003cited by this paper
• EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer

  2003cited by this paper
• Expression profiling predicts outcome in breast cancer

  2002cited by this paper
• Polycomb repression: from cellular memory to cellular proliferation and cancer.

  2002cited by this paper
• Stem cell pluripotency and transcription factor Oct4

  2002cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002cited by this paper
• Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.

  2002cited by this paper
• [Keratin 5-positive cells in the breast are progenitor cells of glandular and myoepithelial differentiation. A cell biological model as a basis of breast pathology].

  2001cited by this paper
• The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

  2001cited by this paper
• Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up.

  2001cited by this paper
• The Prognostic Significance of P-Cadherin in Infiltrating Ductal Breast Carcinoma

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes

  2001cited by this paper
• The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

  2001cited by this paper
• Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

  2001cited by this paper
• Tissue microarrays (TMAs) for high‐throughput molecular pathology research

  2001cited by this paper
• Oct‐4: Gatekeeper in the Beginnings of Mammalian Development

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

  2000cited by this paper
• Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

  2000cited by this paper
• Cutting Edge: Polycomb Gene Expression Patterns Reflect Distinct B Cell Differentiation Stages in Human Germinal Centers

  2000cited by this paper
• Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.

  1999cited by this paper
• Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

  1999cited by this paper
• The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

  1999cited by this paper
• Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

  1998cited by this paper
• Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma

  1997cited by this paper
• Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

  1996cited by this paper
• bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.

  1993cited by this paper
• Characterization and chromosomal localization of the human proto-oncogene BMI-1.

  1993cited by this paper
• The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

  1992cited by this paper
• A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells.

  1990cited by this paper
• A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo

  1990cited by this paper

• Loss of androgen receptor expression is associated with aggressive tumor features and reduced survival in breast cancer patients.

  2025cites this paper
• The combination phenotype of B-cell specific Moloney murine leukaemia virus integration site 1 (BMI1) and CD44+/CD24−/low associates with poor clinicopathological features in African patients with breast cancer

  2021cites this paper
• Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups

  2020cites this paper
• Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma

  2020cites this paper
• Breast cancer stem cells: A fallow research ground in Africa.

  2020cites this paper
• Inhibition of Bmi1 suppresses tumorigenicity in glioma stem cells via the YAP/Pax3 pathway

  2020cites this paper
• Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis

  2019cites this paper
• Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.

  2018cites this paper
• BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells

  2017cites this paper
• Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

  2017cites this paper
• Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2

  2017cites this paper
• Stemness-related markers in cancer

  2017cites this paper
• SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer

  2016cites this paper
• Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer

  2016cites this paper
• Microvascular proliferation in luminal A and basal-like breast cancer subtypes

  2015cites this paper
• Molecular Classification of Breast Cancer

  2015cites this paper
• Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis.

  2014cites this paper
• Pulmonary neuroendocrine tumors: Study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses

  2014cites this paper
• EZH2 T416 Phosphorylation Enhances Breast Cancer Tumorigenesis

  2013cites this paper
• Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.

  2013cites this paper
• Expression of BMI1 and p16 in laryngeal squamous cell carcinoma

  2013cites this paper
• The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030.

  2013cites this paper
• High Expression of CHRNA1 is Associated with Reduced Survival in Early Stage Lung Adenocarcinoma after Complete Resection

  2013cites this paper
• Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer

  2012cites this paper
• Cancer Stem Cell Marker Bmi-1 Expression is Associated with Basal-like Phenotype and Poor Survival in Breast Cancer

  2012cites this paper
• Clinical significance of basal-like breast cancer in Chinese women in Heilongjiang province.

  2012cites this paper
• Overexpression of T‐LAK cell‐originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma

  2012cites this paper
• Nuclear BMI-1 expression in laryngeal carcinoma correlates with lymph node pathological status

  2012cites this paper
• Relationships Between Immunophenotype, Ki-67 Index, Microvascular Density, Ep-CAM/P-cadherin, and MMP-2 Expression in Early-stage Invasive Ductal Breast Cancer

  2012cites this paper
• Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells

  2011cites this paper
• P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer

  2011cites this paper
• Sentinel Node Biopsy and Nodal Staging

  2011cites this paper
• Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance

  2010cites this paper
• Molecular markers in breast carcinoma. A study with focus on molecular phenotypes, angiogenesis and stem cells in an African population

  2010cites this paper
• Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells

  2010cites this paper
• Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1.

  2010cites this paper
• Clinicopathological significance of B-cell-specific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion.

  2009cites this paper
• The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer

  2009cites this paper
• Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

  2009influential citation
• Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer

  2009cites this paper
• Molecular epidemiology, racial/ethnic differences and chemoprevention of breast cancer: Population-based studies from metropolitan Detroit

  2009cites this paper
• Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.

  2009cites this paper
• Basic science: (February 2008)

  2008cites this paper
• EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy

  2008cites this paper
• EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

  2008cites this paper
• Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

  2008cites this paper
• RESEARCH COMMUNICATION Clinical Significance of Basal-like Breast Cancer in Chinese Women in Heilongjiang Province

  year unknowncites this paper